InfoBionic, the company focused on creating superior patient monitoring solutions for chronic disease management, has closed a $17 million Series B financing round, adding new investors Excel Venture Management and Zaffre Investments. In addition, InfoBionic named Steven R. Wasserman as CFO and William G. Swavely as Senior Vice President of IT.

The new funds will enable InfoBionic to commercialize its MoMe System, a remote patient monitoring platform for cardiac arrhythmia detection in Europe and the United States.

“InfoBionic’s cloud-based MoMe platform is a radical leap forward in improving cardiac monitoring, making it easier for patients to be diagnosed, leading to better care and reduced costs,” said Caleb Winder, Managing Director at Excel Venture Management, who has joined InfoBionic’s board of directors.

Steven R. Wasserman, InfoBionic’s new CFO, has more than 30 years’ experience managing corporate finance, accounting, financial planning and analysis, mergers and acquisitions, investor relations, legal, and human resources. On the other hand, William “Bill” G. Swavely, the company’s newly appointed Senior Vice President of IT, has more than 20 years’ experience leading enterprise-wide IT for public and private companies in healthcare, medical devices, pharmaceuticals, contract research organizations, entertainment, private equity, and telecommunications.

InfoBionic will continue to execute against its vision to improve patient monitoring, diagnosis and treatment, ultimately reducing operating and healthcare costs and, most importantly, saving lives.